glp 1 drugs australia Weight loss are rewriting the global business of how we eat Researchers in Australia are issuing

11 Results showed that subcutaneous semaglutide had a hazard ratio (HR) of 1.76 compared to placebo for developing worse diabetic retinopathy (DR) after treatment

Patients with T2D are considered for CVD secondary prevention because their risk level is similar to that reported in nondiabetic patients who have already suffered a MI [3]

Is chronic kidney disease associated with osteoarthritis

In a pilot study, treatment with liraglutide increased glucose utilisation in the brain as detected by (18)F-fluorodeoxyglucose( 18 FDG)-positron emission tomographyPET (PET) scans (66)

Nature 633 , 758760 (2024)

Insulin and leptin levels drop precipitously, both of which have downstream effects on follicular health